Abstract: The present invention relates to compounds, related to 2,3 benzodiazepines, of general formula (I), such as Tofisopam, Girisopam or Nerisopam, for use in the treatment of dyskinesia. The dyskinesia may arise as a side-effect of a therapy for pakinsonism.
Type:
Application
Filed:
September 11, 2003
Publication date:
November 24, 2005
Applicant:
Motac Neuroscience Limited Williams House
Inventors:
Alan Crossman, Michael Hill, Jonathan Brotchie